1/25
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Glycogenesis
is the metabolic pathway that synthesizes glycogen molecules from individual glucose units.
Glycogenesis: major sites
Primarily the Liver (which stores glycogen to maintain blood glucose for the whole body) and Skeletal Muscle (which stores glycogen exclusively for its own local energy needs).
Glycogenesis: Cellular Location & Hormonal Control
Cytoplasm of the cell
Stimulated heavily by Insulin (the fed state hormone); completely shut down by Glucagon and Epinephrine.
Step-by-Step Pathway of Glycogenesis
Building a polymer of glycogen requires a specific sequence of priming, bonding, and branching steps.
Step A: Trapping and Priming Glucose
Step B: The Primer (Glycogenin)
Step C: Elongation (The Rate-Limiting Step)
Step D: Branching (Creating Solubility)
Step A: Trapping and Priming Glucose
Before glucose can be built into a storage chain, it must be chemically activated so it has the energy to bond.
Phosphorylation: Once glucose enters the cell, the enzyme Hexokinase (in muscles) or Glucokinase (in the liver) slaps a phosphate group onto it, turning it into Glucose-6-Phosphate (G6P). This traps the glucose inside the cell so it cannot slip back out through the cell membrane.
Rearrangement: G6P is converted into Glucose-1-Phosphate (G1P) by the enzyme Phosphoglucomutase.
Activation: G1P is combined with UTP (Uridine Triphosphate) via the enzyme UDP-glucose pyrophosphorylase to create UDP-Glucose. UDP-glucose is the actual activated building block used to grow the glycogen chain.
Step B: The Primer (Glycogenin)
Glycogen synthase cannot start building a glycogen chain from absolute zero; it requires a preexisting "starter chain" or primer.
A specialized protein called Glycogenin acts as the anchor. It autocalalyzes the attachment of the first few glucose molecules to itself, creating a small short chain. Once the chain is about 8 glucose units long, Glycogenin steps back and lets the main enzyme take over.
Step C: Elongation (The Rate-Limiting Step)
The Enzyme: Glycogen Synthase (The most heavily tested enzyme in this pathway).
The Action: Glycogen synthase takes the activated glucose from UDP-Glucose and attaches it to the growing chain, forming a alpha-1,4-glycosidic bond.
Board Exam Distinction: Glycogen synthase is responsible for building the long, straight linear chains of glycogen.
Step D: Branching (Creating Solubility)
If glycogen were just one long, straight string, it would tangle and take up too much space. To make it compact and allow rapid breakdown later, the body adds branches.
The Enzyme: Amylo-(1,4 → 1,6)-transglucosidase (commonly called the Branching Enzyme).
The Action: Once a straight chain reaches about 11 glucose units in length, the branching enzyme snips off a block of 5 to 8 glucose units and re-attaches it further up the chain with an alpha-1,6-glycosidic bond, creating a fork in the road.
Regulation and Control (Allosteric & Covalent Modification)
The body tightly regulates Glycogen Synthase so it is only active when energy is abundant.
Covalent Modification (Phosphorylation)
Allosteric Regulation
Covalent Modification (Phosphorylation)
When Insulin is high, Glycogen Synthase is dephosphorylated (active). It aggressively builds glycogen.
When Glucagon or Epinephrine are high (during fasting or stress/fight-or-flight), enzymes phosphorylate Glycogen Synthase, turning it OFF. (This makes logical sense: if you are stressed or starving, your body wants to break down glycogen, not build it).
Allosteric Regulation
Glucose-6-Phosphate acts as a positive allosteric activator, giving direct feedback to the system that raw materials are available and ready to be stored.
Glycogen Storage Diseases (GSDs)
Defects in the enzymes governing glycogen metabolism lead to severe pathological buildup. While defects in glycogenolysis enzymes (like Von Gierke's or Pompe's) tend to cause acute metabolic crises or organ failure, genetic defects directly affecting glycogen synthesis lead to fasting hypoglycemia and muscle cramps due to the inability to maintain adequate energy reserves.
Diabetes Mellitus Connection
In uncontrolled Type 2 Diabetes, insulin signaling is impaired. Because insulin is required to activate glycogenesis and inhibit glycogenolysis, the liver continues to inappropriately push glucose into the blood via unchecked breakdown while completely failing to store incoming glucose.
Glycogenolysis
is not simply the reverse of glycogenesis; it uses entirely different enzymes to systematically dismantle the branched glycogen tree.
Glycogenolysis: Major sites
Primarily the Liver (which breaks down its glycogen to maintain whole-body blood glucose levels) and Skeletal Muscle (which uses its glycogen exclusively to fuel local muscle contractions).
Glycogenolysis: Cellular location, Hormonal control
Cytoplasm of the cell.
Stimulated heavily by Glucagon (in the liver during fasting) and Epinephrine (in muscle and liver during acute stress or exercise); completely shut down by Insulin.
Step-by-Step Pathway of Glycogenolysis
Step A: Shortening the Chains (The Rate-Limiting Step)
Step B: Stoppage at the Branch Points (Limit Dextrin)
Step C: Debranching the Tree
Step D: Converting G1P to Usable Glucose
Step E: The Final Destination (Liver vs. Muscle)
Step A: Shortening the Chains (The Rate-Limiting Step)
The Enzyme: Glycogen Phosphorylase (The most heavily tested enzyme in this pathway).
The Action: Glycogen phosphorylase snips the alpha-1,4-glycosidic bonds along the straight outer branches of the glycogen molecule.
The Clever Trick (Phosphorolysis): Instead of using free water (hydrolysis) to break the bond, it uses inorganic phosphate (Pi). This directly snips off a glucose molecule as Glucose-1-Phosphate (G1P).
Board Exam Advantage: Because it uses an inorganic phosphate rather than ATP to cleave the bond, the cell saves energy—it produces G1P with a phosphate already attached, bypassing the need for a hexokinase investment step!
Step B: Stoppage at the Branch Points (Limit Dextrin)
Glycogen phosphorylase cannot get close to the alpha-1,6 branch points. It stops working when it gets about 4 glucose residues away from a branch point. At this stage, the remaining structure is called a limit dextrin.
Step C: Debranching the Tree
To clear the branch, a specialized dual-action enzyme steps in: The Debranching Enzyme. It has two distinct jobs:
Transferase Activity
Glucosidase Activity
Step D: Converting G1P to Usable Glucose
The vast majority of the broken-down glycogen is now in the form of Glucose-1-Phosphate (G1P).
The Enzyme: Phosphoglucomutase converts G1P into Glucose-6-Phosphate (G6P).
Step E: The Final Destination (Liver vs. Muscle)
What happens to G6P depends entirely on which organ it is in:
In the Liver: The liver contains the enzyme Glucose-6-Phosphatase in its endoplasmic reticulum. This enzyme strips the phosphate off G6P, turning it into free glucose, which can then cross the cell membrane, enter the bloodstream, and normalize blood sugar.
In Skeletal Muscle: Muscle cells completely lack Glucose-6-Phosphatase. Therefore, G6P stays trapped inside the muscle cell and is immediately shoved into glycolysis to generate ATP for muscle contraction.
Regulation: How the Switch is Flipped
Glycogen phosphorylase is controlled through intricate allosteric and covalent modifications.
Covalent Modification (Phosphorylation)
Allosteric Control in Muscle
Covalent Modification (Phosphorylation)
When Glucagon or Epinephrine bind to cellular receptors, they trigger a cascade that uses ATP to phosphorylate Glycogen Phosphorylase, turning it ON (active form: Phosphorylase a).
When Insulin is present, it triggers dephosphorylation, turning the enzyme OFF (inactive form: Phosphorylase b).
Allosteric Control in Muscle
During intense exercise, muscle cells experience a massive buildup of AMP (indicating low energy) and high intracellular calcium (Ca^2+, signaling muscle contraction). Both AMP and calcium act as powerful allosteric activators that force Glycogen Phosphorylase to turn on immediately, even without hormonal signaling.
McArdle Disease (Glycogen Storage Disease Type V)
The Defect: A genetic deficiency of muscle glycogen phosphorylase.
Classic Findings: Because muscles cannot break down their glycogen stores, patients suffer from painful muscle cramps, severe fatigue, and myoglobinuria (dark red urine from muscle breakdown) shortly after beginning intense exercise.
The "Second Wind" Phenomenon: A classic board exam clue! ’blank’ patients experience severe cramping early in exercise, but if they slow down or rest briefly, their body increases blood flow, delivering alternative fuels (fatty acids and blood glucose) to the muscle, allowing them to resume exercising with significantly less pain.